SonoScape Medical Corp - Asset Resilience Ratio
SonoScape Medical Corp (300633) has an Asset Resilience Ratio of 0.21% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of SonoScape Medical Corp for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how SonoScape Medical Corp's Asset Resilience Ratio has changed over time. See SonoScape Medical Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets Composition Over Time
This chart breaks down SonoScape Medical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is SonoScape Medical Corp's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥9.11 Million | 0.21% |
| Total Liquid Assets | CN¥9.11 Million | 0.21% |
Asset Resilience Insights
- Limited Liquidity: SonoScape Medical Corp maintains only 0.21% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SonoScape Medical Corp Industry Peers by Asset Resilience Ratio
Compare SonoScape Medical Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1 |
Medical Devices | 1.05% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Somnomed Ltd
AU:SOM |
Medical Devices | 24.67% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
Annual Asset Resilience Ratio for SonoScape Medical Corp (2018–2025)
The table below shows the annual Asset Resilience Ratio data for SonoScape Medical Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.38% | CN¥237.16 Million ≈ $34.70 Million |
CN¥4.41 Billion ≈ $644.78 Million |
-4.78pp |
| 2024-12-31 | 10.17% | CN¥438.46 Million ≈ $64.16 Million |
CN¥4.31 Billion ≈ $631.13 Million |
+8.80pp |
| 2023-12-31 | 1.36% | CN¥51.39 Million ≈ $7.52 Million |
CN¥3.77 Billion ≈ $551.88 Million |
-10.47pp |
| 2022-12-31 | 11.83% | CN¥419.45 Million ≈ $61.38 Million |
CN¥3.54 Billion ≈ $518.63 Million |
+7.03pp |
| 2021-12-31 | 4.81% | CN¥145.24 Million ≈ $21.25 Million |
CN¥3.02 Billion ≈ $441.97 Million |
-10.97pp |
| 2020-12-31 | 15.78% | CN¥355.32 Million ≈ $51.99 Million |
CN¥2.25 Billion ≈ $329.53 Million |
-12.79pp |
| 2019-12-31 | 28.56% | CN¥689.65 Million ≈ $100.92 Million |
CN¥2.41 Billion ≈ $353.30 Million |
+29.22pp |
| 2018-12-31 | -0.65% | CN¥-11.96 Million ≈ $-1.75 Million |
CN¥1.84 Billion ≈ $268.61 Million |
-- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more